Nuclear Medicine Isotopes - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509243678

Publication Date:

September 30, 2024

Pages:

157

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use. In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.
The global market for Nuclear Medicine Isotopes was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Isotopes, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Nuclear Medicine Isotopes by region & country, by Type, and by Application.
The Nuclear Medicine Isotopes market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Isotopes.
麻豆原创 Segmentation
By Company
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
IRE
Nordion
Curium Pharma
Cambridge Isotope Laboratories
Eckert & Ziegler Strahlen
Polatom
Center of Molecular Research
China National Nuclear Corporation
Urenco
LANL
Shanghai Engineering Research Center
IDB Holland
NHTC
Linde
ORNL
SI Science
Segment by Type:
Stable Isotopes
Radioisotopes
Segment by Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nuclear Medicine Isotopes manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Nuclear Medicine Isotopes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Nuclear Medicine Isotopes in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Nuclear Medicine Isotopes Product Introduction
1.2 Global Nuclear Medicine Isotopes 麻豆原创 Size Forecast
1.3 Nuclear Medicine Isotopes 麻豆原创 Trends & Drivers
1.3.1 Nuclear Medicine Isotopes Industry Trends
1.3.2 Nuclear Medicine Isotopes 麻豆原创 Drivers & Opportunity
1.3.3 Nuclear Medicine Isotopes 麻豆原创 Challenges
1.3.4 Nuclear Medicine Isotopes 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nuclear Medicine Isotopes Players Revenue Ranking (2023)
2.2 Global Nuclear Medicine Isotopes Revenue by Company (2019-2024)
2.3 Key Companies Nuclear Medicine Isotopes Manufacturing Base Distribution and Headquarters
2.4 Key Companies Nuclear Medicine Isotopes Product Offered
2.5 Key Companies Time to Begin Mass Production of Nuclear Medicine Isotopes
2.6 Nuclear Medicine Isotopes 麻豆原创 Competitive Analysis
2.6.1 Nuclear Medicine Isotopes 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Nuclear Medicine Isotopes Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Isotopes as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Stable Isotopes
3.1.2 Radioisotopes
3.2 Global Nuclear Medicine Isotopes Sales Value by Type
3.2.1 Global Nuclear Medicine Isotopes Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nuclear Medicine Isotopes Sales Value, by Type (2019-2030)
3.2.3 Global Nuclear Medicine Isotopes Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Nuclear Therapy
4.1.2 Equipment Radioactive Source
4.1.3 Diagnosis
4.2 Global Nuclear Medicine Isotopes Sales Value by Application
4.2.1 Global Nuclear Medicine Isotopes Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nuclear Medicine Isotopes Sales Value, by Application (2019-2030)
4.2.3 Global Nuclear Medicine Isotopes Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Nuclear Medicine Isotopes Sales Value by Region
5.1.1 Global Nuclear Medicine Isotopes Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nuclear Medicine Isotopes Sales Value by Region (2019-2024)
5.1.3 Global Nuclear Medicine Isotopes Sales Value by Region (2025-2030)
5.1.4 Global Nuclear Medicine Isotopes Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Nuclear Medicine Isotopes Sales Value, 2019-2030
5.2.2 North America Nuclear Medicine Isotopes Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Nuclear Medicine Isotopes Sales Value, 2019-2030
5.3.2 Europe Nuclear Medicine Isotopes Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Nuclear Medicine Isotopes Sales Value, 2019-2030
5.4.2 Asia Pacific Nuclear Medicine Isotopes Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Nuclear Medicine Isotopes Sales Value, 2019-2030
5.5.2 South America Nuclear Medicine Isotopes Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Nuclear Medicine Isotopes Sales Value, 2019-2030
5.6.2 Middle East & Africa Nuclear Medicine Isotopes Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nuclear Medicine Isotopes Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nuclear Medicine Isotopes Sales Value
6.3 United States
6.3.1 United States Nuclear Medicine Isotopes Sales Value, 2019-2030
6.3.2 United States Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nuclear Medicine Isotopes Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nuclear Medicine Isotopes Sales Value, 2019-2030
6.4.2 Europe Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nuclear Medicine Isotopes Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nuclear Medicine Isotopes Sales Value, 2019-2030
6.5.2 China Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nuclear Medicine Isotopes Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nuclear Medicine Isotopes Sales Value, 2019-2030
6.6.2 Japan Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nuclear Medicine Isotopes Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nuclear Medicine Isotopes Sales Value, 2019-2030
6.7.2 South Korea Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nuclear Medicine Isotopes Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nuclear Medicine Isotopes Sales Value, 2019-2030
6.8.2 Southeast Asia Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nuclear Medicine Isotopes Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nuclear Medicine Isotopes Sales Value, 2019-2030
6.9.2 India Nuclear Medicine Isotopes Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nuclear Medicine Isotopes Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 NRG
7.1.1 NRG Profile
7.1.2 NRG Main Business
7.1.3 NRG Nuclear Medicine Isotopes Products, Services and Solutions
7.1.4 NRG Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.1.5 NRG Recent Developments
7.2 NTP Radioisotopes
7.2.1 NTP Radioisotopes Profile
7.2.2 NTP Radioisotopes Main Business
7.2.3 NTP Radioisotopes Nuclear Medicine Isotopes Products, Services and Solutions
7.2.4 NTP Radioisotopes Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.2.5 NTP Radioisotopes Recent Developments
7.3 JSC Isotope
7.3.1 JSC Isotope Profile
7.3.2 JSC Isotope Main Business
7.3.3 JSC Isotope Nuclear Medicine Isotopes Products, Services and Solutions
7.3.4 JSC Isotope Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.3.5 ANSTO Recent Developments
7.4 ANSTO
7.4.1 ANSTO Profile
7.4.2 ANSTO Main Business
7.4.3 ANSTO Nuclear Medicine Isotopes Products, Services and Solutions
7.4.4 ANSTO Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.4.5 ANSTO Recent Developments
7.5 IRE
7.5.1 IRE Profile
7.5.2 IRE Main Business
7.5.3 IRE Nuclear Medicine Isotopes Products, Services and Solutions
7.5.4 IRE Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.5.5 IRE Recent Developments
7.6 Nordion
7.6.1 Nordion Profile
7.6.2 Nordion Main Business
7.6.3 Nordion Nuclear Medicine Isotopes Products, Services and Solutions
7.6.4 Nordion Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.6.5 Nordion Recent Developments
7.7 Curium Pharma
7.7.1 Curium Pharma Profile
7.7.2 Curium Pharma Main Business
7.7.3 Curium Pharma Nuclear Medicine Isotopes Products, Services and Solutions
7.7.4 Curium Pharma Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.7.5 Curium Pharma Recent Developments
7.8 Cambridge Isotope Laboratories
7.8.1 Cambridge Isotope Laboratories Profile
7.8.2 Cambridge Isotope Laboratories Main Business
7.8.3 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Products, Services and Solutions
7.8.4 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.8.5 Cambridge Isotope Laboratories Recent Developments
7.9 Eckert & Ziegler Strahlen
7.9.1 Eckert & Ziegler Strahlen Profile
7.9.2 Eckert & Ziegler Strahlen Main Business
7.9.3 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Products, Services and Solutions
7.9.4 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.9.5 Eckert & Ziegler Strahlen Recent Developments
7.10 Polatom
7.10.1 Polatom Profile
7.10.2 Polatom Main Business
7.10.3 Polatom Nuclear Medicine Isotopes Products, Services and Solutions
7.10.4 Polatom Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.10.5 Polatom Recent Developments
7.11 Center of Molecular Research
7.11.1 Center of Molecular Research Profile
7.11.2 Center of Molecular Research Main Business
7.11.3 Center of Molecular Research Nuclear Medicine Isotopes Products, Services and Solutions
7.11.4 Center of Molecular Research Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.11.5 Center of Molecular Research Recent Developments
7.12 China National Nuclear Corporation
7.12.1 China National Nuclear Corporation Profile
7.12.2 China National Nuclear Corporation Main Business
7.12.3 China National Nuclear Corporation Nuclear Medicine Isotopes Products, Services and Solutions
7.12.4 China National Nuclear Corporation Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.12.5 China National Nuclear Corporation Recent Developments
7.13 Urenco
7.13.1 Urenco Profile
7.13.2 Urenco Main Business
7.13.3 Urenco Nuclear Medicine Isotopes Products, Services and Solutions
7.13.4 Urenco Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.13.5 Urenco Recent Developments
7.14 LANL
7.14.1 LANL Profile
7.14.2 LANL Main Business
7.14.3 LANL Nuclear Medicine Isotopes Products, Services and Solutions
7.14.4 LANL Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.14.5 LANL Recent Developments
7.15 Shanghai Engineering Research Center
7.15.1 Shanghai Engineering Research Center Profile
7.15.2 Shanghai Engineering Research Center Main Business
7.15.3 Shanghai Engineering Research Center Nuclear Medicine Isotopes Products, Services and Solutions
7.15.4 Shanghai Engineering Research Center Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.15.5 Shanghai Engineering Research Center Recent Developments
7.16 IDB Holland
7.16.1 IDB Holland Profile
7.16.2 IDB Holland Main Business
7.16.3 IDB Holland Nuclear Medicine Isotopes Products, Services and Solutions
7.16.4 IDB Holland Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.16.5 IDB Holland Recent Developments
7.17 NHTC
7.17.1 NHTC Profile
7.17.2 NHTC Main Business
7.17.3 NHTC Nuclear Medicine Isotopes Products, Services and Solutions
7.17.4 NHTC Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.17.5 NHTC Recent Developments
7.18 Linde
7.18.1 Linde Profile
7.18.2 Linde Main Business
7.18.3 Linde Nuclear Medicine Isotopes Products, Services and Solutions
7.18.4 Linde Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.18.5 Linde Recent Developments
7.19 ORNL
7.19.1 ORNL Profile
7.19.2 ORNL Main Business
7.19.3 ORNL Nuclear Medicine Isotopes Products, Services and Solutions
7.19.4 ORNL Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.19.5 ORNL Recent Developments
7.20 SI Science
7.20.1 SI Science Profile
7.20.2 SI Science Main Business
7.20.3 SI Science Nuclear Medicine Isotopes Products, Services and Solutions
7.20.4 SI Science Nuclear Medicine Isotopes Revenue (US$ Million) & (2019-2024)
7.20.5 SI Science Recent Developments
8 Industry Chain Analysis
8.1 Nuclear Medicine Isotopes Industrial Chain
8.2 Nuclear Medicine Isotopes Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nuclear Medicine Isotopes Sales Model
8.5.2 Sales Channel
8.5.3 Nuclear Medicine Isotopes Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

NRG
NTP Radioisotopes
JSC Isotope
ANSTO
IRE
Nordion
Curium Pharma
Cambridge Isotope Laboratories
Eckert & Ziegler Strahlen
Polatom
Center of Molecular Research
China National Nuclear Corporation
Urenco
LANL
Shanghai Engineering Research Center
IDB Holland
NHTC
Linde
ORNL
SI Science

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.